| COMPOSITION: | Each uncoated bilayered tablet contains Levocetirizine Dihydrochloride 5 mg, Montelukast Sodium 10 mg & Ambroxol Hydrochloride SR 75 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Relikast-LX tablet contains Montelukast, a Leukotriene inhibitor that effectively treat inflammation & oedema associated with allergy; Levocetirizine, an anti-allergic drug & Ambroxol in sustain release form, a mucolytic drug that removes mucus from respiratory tract. It is prescribed in case of long standing asthma, chest congestion and respiratory tract congestion due to allergic mucus manifestation as well as other chronic respiratory hyper secretory allergic disorders. |
| SIDE EFFECTS: | Dry mouth, diarrhea, nausea, vomiting, loss of appetite, muscle weakness, difficulty in breathing, fever & abdominal pain are the observed side effect. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
